Abvc Biopharma Inc (ABVC)

Überblick Nachrichten Preisverlauf Financials Warum fällt ABVC? Forum Prognose Aktiensplit

Warum fällt Abvc Biopharma Inc-Aktie (ABVC)?

Wir haben während der Handelssitzung 2024-11-15 einen Rückgang der Aktie Abvc Biopharma Inc (ABVC) um 9.26% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!

2023-11-27:

Shares of ABVC Biopharma (ABVC) dropped by 16.83% from $2.02 to $1.68 in the trading on Monday, November 27, 2023. The reason why ABVC is down today is due to news regarding the company's entry into a convertible agreement and subsequent dilution as of November 27, 2023, based on new shareholders. In this agreement, ABVC BioPharma issued a $1.2 million convertible note to Lind Global Fund II, LP, with a conversion price set at $3.50 per share. This issuance of convertible notes can lead to potential dilution of existing shares, which often exerts downward pressure on the stock price. This news likely contributed to the notable decrease in ABVC's stock price.

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%

Abvc Biopharma Inc (ABVC)

Warum fällt Abvc Biopharma Inc-Aktie (ABVC)?

Ähnlich wie ABVC